Subcutaneous immunoglobulins: product characteristics and their role in primary immunodeficiency disease.
about
II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies.Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North America.Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies.Immune globulin (human) 10 % liquid: a review of its use in primary immunodeficiency disorders.
P2860
Subcutaneous immunoglobulins: product characteristics and their role in primary immunodeficiency disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Subcutaneous immunoglobulins: ...... mary immunodeficiency disease.
@en
type
label
Subcutaneous immunoglobulins: ...... mary immunodeficiency disease.
@en
prefLabel
Subcutaneous immunoglobulins: ...... mary immunodeficiency disease.
@en
P2093
P2860
P1476
Subcutaneous immunoglobulins: ...... mary immunodeficiency disease.
@en
P2093
Alessandro Testori
Isaac Melamed
Zvi Spirer
P2860
P304
P356
10.3109/08830185.2012.732631
P577
2012-12-01T00:00:00Z